FDA Finalizes Guidance on Sponsor Responsibilities for Safety Reporting in IND and BA/BE Studies

The FDA has finalized its 2025 guidance for sponsors on safety reporting in IND and BA/BE studies. Learn what manufacturers must update and how it affects your trials.